Ivan L. Moody - Lead Singer of Five Finger Death Punch - Announces Additional Products For New CBD Wellness Line 'Moody's Medicinals'
Launch Event Set For Saturday, November 2 At The Grove - Las Vegas
LAS VEGAS, NV - October 4, 2019 (Investorideas.com Newswire) Moody's Medicinals, Inc.™ a health and wellness innovator specializing in both Cannabidiol ("CBD") and non-CBD health and wellness products launched its trailblazing line of high-quality products in June 2019. Today, October 3, Moody's Medicinals is introducing a new range of sugar-free AM and PM shots. The Moody's Medicinals shots are both certified pure CBD; the AM Shot offers a refreshing Raspberry Lemonade and the PM Shot comes in a calming Lemon Iced Tea flavor. The new products join the previously announced Moody's Medicinals line which includes a lemon-infused CBD water and a Peppermint throat potion spray in both CBD and non-CBD formulas.
Ivan will kick off an official Moody's Medicinals launch event on Saturday, November 2 at 1:00 pm at The Grove--Las Vegas, NV (4647 Swenson Street, Las Vegas, NV 89119). That same weekend, Five Finger Death Punch will kick off their Fall 2019 U.S. Arena Headlining Tour with two exclusive launch shows in their hometown of Las Vegas on Friday, November 1 and Saturday, November 2 at THE JOINT at Hard Rock Hotel & Casino.
Ivan Moody realized that Moody's Medicinals could provide better ingredients, quality, and potency across its products. "It became important for us to continue listening and innovate on all of the ways people have made Moody's Medicinals a part of their lives," explains Ivan L. Moody, creator of Moody's Medicinals. "The AM and PM shots will not only complement the additional products I used to tame my anxiety, but they help me start and finish the day calm and focused. I am not able to eat on a normal schedule when I'm out on tour, so these products help manage my appetite."
Five Finger Death Punch's world-renowned lead vocalist, Ivan L. Moody, created Moody's Medicinals because taking CBD helped him personally manage his anxiety symptoms, PTSD and OCD. However, he noticed a gap in the marketplace concerning the extreme amounts of additives that competing brands used. Ivan set out to deliver a variety of CBD and non-CBD health and wellness products that that do not contain sugars, alcohols and unnecessary additives.
All of the Moody's Medicinals product lines are available for purchase at retail locations and worldwide online at MoodysMedicinals.com. The new products are available for pre-order.
Moody's Medicinals continues to comply in full with all federal, state and local laws, rules and regulations as Moody's Medicinals develops its CBD/hemp extract product lines.
Moody's Medicinals are a registered trademark of ILM Distribution, Inc.
For more information and promotions, please follow MOODY'S MEDICINALS at: www.MoodysMedicinals.com
Facebook: MoodysMedicinals
Twitter: @MoodysMedicinal
Instagram: @MoodysMedicinals
Disclaimer: The Food and Drug Administration has not evaluated the statements made regarding these products. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease. All information presented here is not a substitute for or alternative to information from healthcare practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.
To arrange interviews, reviews and for Ivan Moody and Moody's Medicinals publicity enquiries, please contact:
Libby Coffey
PRIME PR GROUP, INC.
+1 626-676-4993
LCoffey@primeprgroup.com
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
